A clinical trial To study the effect of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa roga w.s.r. To COPD
Phase 2
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2023/11/059565
- Lead Sponsor
- Dr Anjana Mishra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having Prolonged expiration with pursed lip breathing, barrel shaped chest, central or peripheral cyanosis, diminished expansion of chest,use of accessory muscles
Exclusion Criteria
Patients presenting with complications like advanced type 2 respiratory failure, lung collapse and pneumothorax
Patients showing more than 12% increment in FEV1/FVC ratio after bronchodilation with 2 puffs of salbutamol 100mcg/puff
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala churna in the management of Shwasa Roga w.s.r. to Chronic obstructive Pulmonary Disease (COPD) <br/ ><br> <br/ ><br>To compare the effect of Bharangyadi Kwatha and Kaliphala Churna with Doxophylline in the management of Shwasa Roga w.s.r.to Chronic Obstructive Pulmonary Disease (COPD)Timepoint: 30 days
- Secondary Outcome Measures
Name Time Method To assess the clinical safety of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa Roga w.s.r to Chronic Obstructive pulmonary Disease (COPD)Timepoint: 30 days